The Role of Olfactory Testing in Detecting Prodromal Phase Parkinson’s Disease: A Literature Review
DOI:
https://doi.org/10.19166/lijn.v2i2.11522Schlagworte:
Olfactory Testing, Hyposmia, Prodromal Phase, Cross-Cultural Adaptation, Parkinson's DiseaseAbstract
Introduction: Parkinson's disease (PD) is a progressive neurodegenerative disorder traditionally diagnosed based on classic motor symptoms. However, these motor manifestations appear only after a substantial loss of dopaminergic neurons in the substantia nigra. Detecting PD during its prodromal phase offers a crucial therapeutic window to potentially delay disease progression. Hyposmia is one of the earliest and most prevalent non-motor markers, appearing up to a decade before motor onset.
Methods: A comprehensive literature search was conducted across electronic databases, including PubMed, Cochrane Library, and Google Scholar. The inclusion criteria were restricted to original research articles published within the last five years (2021–2026) in English or Indonesian. Data regarding olfactory testing accuracy and cultural adaptation were synthesized.
Results: Standardized olfactory assessment tools, such as the University of Pennsylvania Smell Identification Test (UPSIT), Sniffin' Sticks, and the Brief Smell Identification Test (B-SIT), demonstrate high sensitivity (79%) and specificity (81%) in distinguishing PD from diagnostic mimics. Nevertheless, international screening tools frequently suffer from cross-cultural bias due to unfamiliarity with Western odorants. Emerging evidence indicates that adapting these instruments using locally familiar Asian and Indonesian olfactory stimuli (e.g., coffee, jasmine, aromatic ginger, and cajuput oil) significantly optimizes diagnostic accuracy.
Conclusions: Brief olfactory assessments, particularly those tailored to regional and cultural settings, serve as highly effective, cost-efficient, and non-invasive screening instruments for prodromal PD detection within routine neurogeriatric clinical practice.
Keywords: Parkinson's Disease, Olfactory Testing, Hyposmia, Prodromal Phase, Cross-Cultural Adaptation
Literaturhinweise
1. Zafar S, Lui F, Yaddanapudi SS. Parkinson disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Sep 15. Available from: https://www.ncbi.nlm.nih.gov/books/NBK470193/
2. Heng N, Malek N, Lawton MA, Nodehi A, Pitz V, Grosset KA, et al. Striatal dopamine loss in early parkinson's disease: systematic review and novel analysis of dopamine transporter imaging. Movement Disorders Clinical Practice. 2023;10(4):539–546. Available from: https://doi.org/10.1002/mdc3.13687
3. Zulfitri R, Nuha A. Neurological and clinical aspects of parkinson’s disease. Galenical: Jurnal Kedokteran dan Kesehatan Mahasiswa Malikussaleh. 2025. Available from: https://doi.org/10.29103/jkkmm.v4i5.23854
4. International Parkinson and Movement Disorder Society (MDS). Animal model of prodromal parkinson's disease. MDS Committee Report; 2021. Available from: https://id.movementdisorders.org/MDS/Masalah-Ilmiah/Model-Hewan-Penyakit-Parkinson-Prodromal.htm
5. Hustad E, Aasly J. Clinical and imaging markers of prodromal parkinson's disease. Frontiers in Neurology. 2020;11:395.parkinson's disease. Frontiers in Neurology. 2020;11:395. Available from: https://doi.org/10.3389/fneur.2020.00395
6. Cao M, Wang N, Zheng P, Gu Z, Chan P. Validation of a new olfactory test for Chinese Parkinson’s disease patients. Journal of Clinical Neuroscience. 2020;76:31-35. Available from: https://doi.org/10.1016/j.jocn.2020.04.068
7. Torres-Pasillas G, Chi-Castañeda D, Carrillo-Castilla P, Marín G, Hernández-Aguilar ME, Aranda-Abreu GE, et al. Olfactory dysfunction in parkinson's disease, its functional and neuroanatomical correlates. NeuroSci. 2023;4(2):134-151. Available from: https://doi.org/10.3390/neurosci4020013
8. Lin YH, Fang TC, Lei HB, Chiu SC, Chang MH, Guo YJ. UPSIT subitems may predict motor progression in Parkinson's disease. Frontiers in Neurology. 2023;14:1265549. Available from: https://doi.org/10.3389/fneur.2023.1265549
9. Trentin JS, de Oliveira AR, Santos GC, et al. Evaluation of the complete Sniffin Sticks Test versus its subtests in differentiating Parkinson's disease patients from healthy controls. Arquivos de Neuro-Psiquiatria. 2022;80(09):908–915. Available from: https://doi.org/10.1055/s-0042-1755268
10. Jiang RS, Chiang YF. A pilot study of the computerized Brief Smell Identification Test. Diagnostics (Basel). 2024;14(19):2121. Available from: https://doi.org/10.3390/diagnostics14192121
11. Alonso CCG, Silva FG, Costa LOP, Freitas SMSF. Smell tests to distinguish Parkinson's disease from other neurological disorders: a systematic review and meta-analysis. Expert Rev Neurother. 2021;21(3):365-379. Available from: https://doi.org/10.1080/14737175.2021.1886925
12. Bloem BR, Okun MS, Klein C. Parkinson's disease. Lancet. 2021;397(10291):2284–2303. Available from: https://doi.org/10.1016/s0140-6736(21)00218-x
13. Theyer C, Kirchmair J, Jagusch F, Leiter S, Djamshidian A, Heim B, et al. The utility of olfactory testing to discriminate parkinson's disease from diagnostic mimics: a systematic review and meta-analysis. Eur J Neurol. 2026;33(1):e70473. Available from: https://doi.org/10.1111/ene.70473
14. Indonesian Researcher Group. Cultural adaptation and normative data for olfactory testing in the Indonesia's older adult population. Oto Rhino Laryngologia (ORLI). 2025;55(2):103–112. Available from: https://doi.org/10.32637/orli.v55i2.736
